Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Final CTU new 2019 masthead1

October 3rd, 2022

View Archives Issues

  • While use of new methods grows, OCs remain lead contraceptive choice

    While new methods are gaining favor with women, oral contraceptives (OCs) continue to be a popular method of birth control, say respondents to the 2008 Contraceptive Technology Update Contraception Survey. About 42% of survey participants report over half of their patients leave the office with an OC prescription in hand.
  • Check OC options: Readers share views

    Where do generic oral contraceptives fit in your facility's formulary? About 70% of participants in the 2008 Contraceptive Technology Update Contraception Survey say their facilities have increased the use of generic oral contraceptives due to budget constraints, up 5% from 2007's statistic.
  • Strategies for the Pill: Providers share views

    When it comes to oral contraceptives (OCs), what is your current practice when it comes to prescribing pills in extended- or continuous- regimens? More providers are prescribing pills in this manner, say respondents to the 2008 Contraceptive Technology Update Contraception Survey. About 62% say they increased use of such pill regimens in the last year.
  • Intrauterine devices — More women eye option

    Use of intrauterine contraception is slowly gaining ground among U.S. women. About 45% of respondents to the 2008 Contraceptive Technology Update Contraception Survey say they inserted six or more devices in the last year, compared to 2007's 40% figure. About 40% reported no insertions in 2008, similar to 2007's statistic.
  • Shot makes its mark in contraceptive options

    When it comes to choosing an effective contraceptive, many women look to the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo-Provera Pfizer; New York City, Medroxyprogesterone Acetate Injection, Teva Pharmaceuticals USA; North Wales, PA), say respondents to the 2008 Contraceptive Technology Update Contraception Survey.
  • Teen Topics: Get focused on status of teen sexual health

    To prevent pregnancy and disease in adolescents, health professionals seek to help teens delay sexual activity and increase condom and contraception use among those who are sexually active. Throughout the 1990s, those efforts appeared successful.